Literature DB >> 20221898

In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening.

Xiao Hua Ma1, Zhe Shi, Chunyan Tan, Yuyang Jiang, Mei Lin Go, Boon Chuan Low, Yu Zong Chen.   

Abstract

Multi-target drugs against selective multiple targets improve therapeutic efficacy, safety and resistance profiles by collective regulations of a primary therapeutic target together with compensatory elements and resistance activities. Efforts have been made to employ in-silico methods for facilitating the search and design of selective multi-target agents. These methods have shown promising potential in facilitating drug discovery directed at selective multiple targets.

Mesh:

Substances:

Year:  2010        PMID: 20221898     DOI: 10.1007/s11095-010-0065-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  96 in total

1.  Collaborative filtering on a family of biological targets.

Authors:  Dumitru Erhan; Pierre-Jean L'heureux; Shi Yi Yue; Yoshua Bengio
Journal:  J Chem Inf Model       Date:  2006 Mar-Apr       Impact factor: 4.956

2.  Predicting the predictability: a unified approach to the applicability domain problem of QSAR models.

Authors:  Horvath Dragos; Marcou Gilles; Varnek Alexandre
Journal:  J Chem Inf Model       Date:  2009-07       Impact factor: 4.956

3.  Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.

Authors:  Rafael Gozalbes; Laurence Simon; Nicolas Froloff; Eric Sartori; Claude Monteils; Romuald Baudelle
Journal:  J Med Chem       Date:  2008-05-15       Impact factor: 7.446

4.  The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases.

Authors:  Stuart Emanuel; Catherine A Rugg; Robert H Gruninger; Ronghui Lin; Angel Fuentes-Pesquera; Peter J Connolly; Steven K Wetter; Beth Hollister; Walter W Kruger; Cheryl Napier; Linda Jolliffe; Steven A Middleton
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

5.  Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy.

Authors:  Lynsey A McHugh; Marina Kriajevska; John K Mellon; Thomas R Griffiths
Journal:  Urology       Date:  2007-02       Impact factor: 2.649

6.  A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer.

Authors:  Richard D Carvajal; Archie Tse; Manish A Shah; Robert A Lefkowitz; Mithat Gonen; Lisa Gilman-Rosen; Jeremy Kortmansky; David P Kelsen; Gary K Schwartz; Eileen M O'Reilly
Journal:  Pancreatology       Date:  2009-05-19       Impact factor: 3.996

7.  Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.

Authors:  Rakesh Kumar; Victoria B Knick; Sharon K Rudolph; Jennifer H Johnson; Renae M Crosby; Ming-Chih Crouthamel; Teresa M Hopper; Charles G Miller; Laura E Harrington; James A Onori; Robert J Mullin; Tona M Gilmer; Anne T Truesdale; Andrea H Epperly; Amogh Boloor; Jeffrey A Stafford; Deirdre K Luttrell; Mui Cheung
Journal:  Mol Cancer Ther       Date:  2007-07       Impact factor: 6.261

8.  Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.

Authors:  Anne S Tsao; Dandan He; Babita Saigal; Suyu Liu; J Jack Lee; Srinivasa Bakkannagari; Nelson G Ordonez; Waun Ki Hong; Ignacio Wistuba; Faye M Johnson
Journal:  Mol Cancer Ther       Date:  2007-07       Impact factor: 6.261

9.  Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines.

Authors:  Yasuyuki Deguchi; Shinya Kimura; Eishi Ashihara; Tomoko Niwa; Keiko Hodohara; Yoshihide Fujiyama; Taira Maekawa
Journal:  Leuk Res       Date:  2008-01-08       Impact factor: 3.156

Review 10.  Imatinib treatment for gastrointestinal stromal tumour (GIST).

Authors:  Lisandro F Lopes; Carlos E Bacchi
Journal:  J Cell Mol Med       Date:  2009-11-28       Impact factor: 5.310

View more
  32 in total

1.  Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase.

Authors:  Lena Hefke; Kerstin Hiesinger; W Felix Zhu; Jan S Kramer; Ewgenij Proschak
Journal:  ACS Med Chem Lett       Date:  2020-04-08       Impact factor: 4.345

2.  Multiple Target Drug Design Using LigBuilder 3.

Authors:  Xiaoyu Qing; Shiwei Wang; Yaxia Yuan; Jianfeng Pei; Luhua Lai
Journal:  Methods Mol Biol       Date:  2021

3.  System-level multi-target drug discovery from natural products with applications to cardiovascular diseases.

Authors:  Chunli Zheng; Jinan Wang; Jianling Liu; Mengjie Pei; Chao Huang; Yonghua Wang
Journal:  Mol Divers       Date:  2014-05-04       Impact factor: 2.943

Review 4.  Cardiac models in drug discovery and development: a review.

Authors:  Robert K Amanfu; Jeffrey J Saucerman
Journal:  Crit Rev Biomed Eng       Date:  2011

Review 5.  Bioinformatics and variability in drug response: a protein structural perspective.

Authors:  Jennifer L Lahti; Grace W Tang; Emidio Capriotti; Tianyun Liu; Russ B Altman
Journal:  J R Soc Interface       Date:  2012-05-02       Impact factor: 4.118

6.  Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir.

Authors:  Li Xie; Thomas Evangelidis; Lei Xie; Philip E Bourne
Journal:  PLoS Comput Biol       Date:  2011-04-28       Impact factor: 4.475

7.  Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.

Authors:  Premkumar Jayaraman; Kishore R Sakharkar; ChuSing Lim; Mohammad Imran Siddiqi; Sarinder K Dhillon; Meena K Sakharkar
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

8.  Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.

Authors:  Mahmoud Elhefnawi; Mohammad ElGamacy; Mohamed Fares
Journal:  BMC Bioinformatics       Date:  2012-12-13       Impact factor: 3.169

9.  An innovative strategy for dual inhibitor design and its application in dual inhibition of human thymidylate synthase and dihydrofolate reductase enzymes.

Authors:  Mahreen Arooj; Sugunadevi Sakkiah; Guang ping Cao; Keun Woo Lee
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Computational analysis and predictive modeling of polymorph descriptors.

Authors:  Yugyung Lee; Sourav Jana; Gayathri Acharya; Chi H Lee
Journal:  Chem Cent J       Date:  2013-02-04       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.